125.23
1.81 (1.47%)
| Previous Close | 123.42 |
| Open | 124.22 |
| Volume | 203,825 |
| Avg. Volume (3M) | 410,119 |
| Market Cap | 4,468,678,144 |
| Price / Earnings (TTM) | 85.19 |
| Price / Sales | 4.70 |
| Price / Book | 3.41 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2026 |
| Profit Margin | 7.42% |
| Operating Margin (TTM) | 12.84% |
| Diluted EPS (TTM) | 1.95 |
| Quarterly Revenue Growth (YOY) | 1.10% |
| Quarterly Earnings Growth (YOY) | 44.50% |
| Total Debt/Equity (MRQ) | 57.49% |
| Current Ratio (MRQ) | 2.56 |
| Operating Cash Flow (TTM) | 157.37 M |
| Levered Free Cash Flow (TTM) | 152.43 M |
| Return on Assets (TTM) | 5.75% |
| Return on Equity (TTM) | 9.73% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (US) | Bullish | Bullish |
| Scientific & Technical Instruments (Global) | Bullish | Bullish | |
| Stock | Novanta Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 5.0 |
| Average | 1.25 |
|
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Small Core |
| % Held by Insiders | 0.86% |
| % Held by Institutions | 105.06% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 22 Jan 2026 | Announcement | Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |